GNTLF Stock Price, Chart, Stats & News

Genetic Technologies Limited, trading as GNTLF, is an Australian molecular diagnostics enterprise dedicated to creating and delivering advanced predictive assessment instruments. These tools are designed to assist medical professionals in Australia and the United States with managing women's health. The company's primary offering is BREVAGenplus, a meticulously validated risk evaluation test specifically for non-inherited breast cancer.